Circulatory disease, cardiovascular disease, cancer
Conditions
Interventions
University Casebook Series:None
Sponsors
Fujian Maternity and Child Health Hospital
Eligibility
Sex/Gender
All
Inclusion criteria
Inclusion criteria: 1. Patients who have used anticoagulants (rivaroxaban, dabigatran, apixaban, edoxaban, heparin, low molecular heparin, flavta heparin sodium, warfarin); 2. Detailed information on the patient's basic medical history and treatment process; 3. Clear information on the purpose of medication, dosage and medication regimen.
Exclusion criteria
Exclusion criteria: Incomplete information on patient medication.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Efficacy and safety outcomes;Evaluation of drug use; | — |
Secondary
| Measure | Time frame |
|---|---|
| adverse reaction;Analysis of compliance;Construction of hemorrhage and thrombus model;drug interactions;Economic evaluation; | — |
Countries
China
Contacts
Public ContactJinhua Zhang
Fujian Maternity and Child Health Hospital
Outcome results
None listed